Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Nila Kartika Wati October 18, 2026

A pioneering clinical trial has commenced, marking a significant step forward in the development of MGC030, an...

Read More Read more about MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Layla Zulfa October 17, 2026

Norman, OK – In a significant stride towards understanding and potentially treating one of the most aggressive...

Read More Read more about Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Reynand Wu October 17, 2026

Biopharmaceutical company MacroGenics has announced the commencement of a Phase I clinical trial for its investigational antibody-drug...

Read More Read more about MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Unmasking Cancer’s Cunning Strategy: Oklahoma Research Reveals How Tumors Manipulate the Immune System to Grow

• Medical Research and Clinical Trials

Unmasking Cancer’s Cunning Strategy: Oklahoma Research Reveals How Tumors Manipulate the Immune System to Grow

Asro October 17, 2026

NORMAN, OK – In a significant breakthrough that could redefine future cancer treatments, researchers at the University...

Read More Read more about Unmasking Cancer’s Cunning Strategy: Oklahoma Research Reveals How Tumors Manipulate the Immune System to Grow

MacroGenics Advances Promising Antibody-Drug Conjugate MGC030 into Human Clinical Trials for Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Advances Promising Antibody-Drug Conjugate MGC030 into Human Clinical Trials for Advanced Solid Tumors

Dwi Wanna October 17, 2026

ROCKVILLE, MD – [Insert Date] – MacroGenics, Inc., a biopharmaceutical company dedicated to developing innovative cancer therapies,...

Read More Read more about MacroGenics Advances Promising Antibody-Drug Conjugate MGC030 into Human Clinical Trials for Advanced Solid Tumors

Unveiling a Stealthy Alliance: Oklahoma Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

• Medical Research and Clinical Trials

Unveiling a Stealthy Alliance: Oklahoma Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

Ammar Sabilarrohman October 17, 2026

NORMAN, OK – In a significant stride toward understanding and potentially disarming one of cancer’s most aggressive...

Read More Read more about Unveiling a Stealthy Alliance: Oklahoma Researchers Discover How Aggressive Breast Cancer Hijacks Immune Cells to Fuel Growth

MacroGenics Initiates Phase I Trial for Promising Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Promising Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Evan Lee Salim October 17, 2026

A new frontier in cancer treatment is being explored as MacroGenics, a clinical-stage biopharmaceutical company, has successfully...

Read More Read more about MacroGenics Initiates Phase I Trial for Promising Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Unveiling Cancer’s Cunning Strategy: Oklahoma Research Exposes How Aggressive Breast Tumors Recruit Nerves to Fuel Growth

• Medical Research and Clinical Trials

Unveiling Cancer’s Cunning Strategy: Oklahoma Research Exposes How Aggressive Breast Tumors Recruit Nerves to Fuel Growth

Suro Senen October 16, 2026

NORMAN, OK – In a significant breakthrough poised to redefine our understanding of aggressive breast cancers, new...

Read More Read more about Unveiling Cancer’s Cunning Strategy: Oklahoma Research Exposes How Aggressive Breast Tumors Recruit Nerves to Fuel Growth

MacroGenics Initiates Phase I Trial for Promising Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Promising Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Iffa Jayyana October 16, 2026

New York, NY – [Date of publication] – MacroGenics, Inc., a biopharmaceutical company at the forefront of...

Read More Read more about MacroGenics Initiates Phase I Trial for Promising Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Unveiling Cancer’s Neural Hijack: Oklahoma Researchers Discover How Breast Tumors Recruit Nerves to Fuel Growth

• Medical Research and Clinical Trials

Unveiling Cancer’s Neural Hijack: Oklahoma Researchers Discover How Breast Tumors Recruit Nerves to Fuel Growth

Siti Muinah October 16, 2026

Norman, OK – In a significant breakthrough that redefines our understanding of cancer progression, researchers at the...

Read More Read more about Unveiling Cancer’s Neural Hijack: Oklahoma Researchers Discover How Breast Tumors Recruit Nerves to Fuel Growth